Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Artificial pancreas Stories

2009-06-06 10:00:00

Two-year study presented at the American Diabetes Association's 69th Scientific Sessions shows investigational product comparable to standard insulin therapy in pulmonary function tests NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin with changes in pulmonary function tests comparable to usual antidiabetic treatment, according to data presented today at the American Diabetes Association's...

2009-05-29 12:30:41

Critical appraisal of continuous glucose monitoring technology is focus of Diabetes Technology & Therapeutics supplement Continuous Glucose Monitoring (CGM) devices represent a critical step toward achieving automated glucose measurement, offering people with diabetes a promising new tool for maintaining optimal glucose control. A comprehensive review of this rapidly changing field, featuring the most recent research findings and critical analysis, is the focus of a special supplement of...

2009-05-26 10:51:00

CHICAGO, May 26 /PRNewswire/ -- The Juvenile Diabetes Research Foundation Illinois, the state chapter of the leading charitable funder and advocate of type 1 diabetes research worldwide, has named Glen Tullman, Chief Executive Officer of Allscripts (Nasdaq: MDRX), its "Best of Illinois" for his service on the Illinois Board of Directors, on the International Board, and for his support of the organization's efforts in developing an artificial pancreas. (Logo:...

2009-05-13 15:47:07

Taking antioxidants such as vitamins C and E may nullify the benefit of exercise to reduce the risk of diabetes, U.S. researchers suggest. Dr. C. Ronald Kahn of the Joslin Diabetes Center and Harvard Medical School in Boston says that part of the reason that exercise improves insulin sensitivity is that it causes oxidative stress on the muscles, HealthDay reported. Insulin resistance occurs when the cells of the body become resistant to the effects of insulin increasing blood sugar and...

2009-04-30 16:21:18

The U.S. Food and Drug Administration announced a recall of Accu-Chek Spirit insulin pumps due to a potential malfunction. The FDA said Disetronic Medical Systems Inc. is recalling pumps with serial numbers from SN02119552 through SN10006093. The company said it took the action after identifying a potential defect in the up and/or down buttons of some insulin pumps. The failure, the FDA said, might present as an intermittent or complete loss of function of the up and/or down buttons that are...

e998da8cfc1fdce592aef90deeb9bc0b1
2009-04-24 11:15:00

Biomedical engineers at University of Calgary design electronic device for quick and painless glucose test to aid diabetics A skin patch could one day provide a less-invasive alternative for diabetics who need to take regular samples of their own blood to keep glucose levels in check. The common method of drawing blood from fingertips and using glucose testing strips and meters can be painful, inconvenient and time-consuming. Electrical engineers at the Schulich School of Engineering at the...

2009-03-31 06:00:00

- Key Step in Ongoing Research to Replicate Insulin-Producing Function of Healthy Pancreas for Type 1 Diabetes Patients - SANTA BARBARA, Calif., March 31 /PRNewswire/ -- A key step toward the successful development of an artificial pancreas for patients with diabetes has been achieved, according to new research published in this month's issue of Diabetes Technology & Therapeutics. Researchers at the University of California at Santa Barbara, Sansum Diabetes Research Institute and...

2009-01-22 08:41:24

Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s. In recent years, research has focused on the anatomical sites best suited for hosting transplanted islet cells. Experimental sites have included the spleen, liver, peritoneal cavity, omentum, subcutaneous tissues and gastric submucosa. However, many transplant attempts at a variety of anatomical sites have failed because of a variety of...

2009-01-01 10:05:01

Discovery moves diabetes type 1 cure closer to clinical application In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients. At present, cell transplantation therapy is limited because transplant recipients are forced to take powerful immunosuppressant...

2008-11-26 09:02:30

Researchers identified a new source of insulin-producing cells. Results of a new study show cells in the pancreas that produce insulin -- called beta cells -- can form after birth or after injury from another, unrelated kind of cell. The unrelated cells, called pancreatic duct cells, can differentiate into the insulin-producing cells. The finding contradicts widely-cited research published in 2004 that suggested new beta cells could only come about through the division of existing beta...